These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7389184)

  • 1. Sialidosis: delineation of subtypes by neuraminidase assay.
    O'Brien JS; Warner TG
    Clin Genet; 1980 Jan; 17(1):35-8. PubMed ID: 7389184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Km defect in neuraminidase of dysmorphic type sialidosis with and without beta-galactosidase deficiency.
    Ben-Yoseph Y; Momoi T; Baylerian MS; Nadler HL
    Clin Chim Acta; 1982 Aug; 123(3):233-40. PubMed ID: 6811161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 2'-(4-methylumbelliferyl)-alpha-D-N-acetylneuraminic acid and detection of skin fibroblast neuraminidase in normal humans and in sialidosis.
    Warner TG; O'Brien JS
    Biochemistry; 1979 Jun; 18(13):2783-7. PubMed ID: 476051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on sialidosis and mucolipidosis. Properties of neuraminidase in cultured skin fibroblasts].
    Beauregard G; Melançon SB; Dallaire L; Potier M
    Biochim Biophys Acta; 1982 Sep; 706(2):212-20. PubMed ID: 7126599
    [No Abstract]   [Full Text] [Related]  

  • 5. Oligosaccharide and ganglioside neuraminidase activities of mucolipidosis I (sialidosis) and mucolipidosis II (I-cell disease) fibroblasts.
    Cantz M; Messer H
    Eur J Biochem; 1979 Jun; 97(1):113-8. PubMed ID: 477659
    [No Abstract]   [Full Text] [Related]  

  • 6. Ganglioside GM3 sialidase activity in fibroblasts of normal individuals and of patients with sialidosis and mucolipidosis IV. Subcellular distribution and and some properties.
    Lieser M; Harms E; Kern H; Bach G; Cantz M
    Biochem J; 1989 May; 260(1):69-74. PubMed ID: 2775195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuraminidase studies in sialidosis.
    Cantz M
    Adv Exp Med Biol; 1980; 125():415-30. PubMed ID: 7189082
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuraminidase activity in the mucolipidoses (types I, II and III) and the cherry-red spot myoclonus syndrome.
    Potier M; Beauregard G; Bélisle M; Mameli L; Hong VN; Melançon SB; Dallaire L
    Clin Chim Acta; 1979 Dec; 99(2):97-105. PubMed ID: 574433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mucolipidosis II (I cell disease): a sialidosis?].
    Farriaux JP; Strecker G
    Arch Fr Pediatr; 1979 Mar; 36(3):225-34. PubMed ID: 485767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytically defective ganglioside neuraminidase in mucolipidosis IV.
    Ben-Yoseph Y; Momoi T; Hahn LC; Nadler HL
    Clin Genet; 1982 Jun; 21(6):374-81. PubMed ID: 6813002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial characterization and studies of fibroblast and leucocyte neuraminidase activities towards sialyloligosaccharides in adult sialidosis and mucolipidosis II and III.
    Kuriyama M; Someya F; Miyatake T; Koseki M
    Biochim Biophys Acta; 1981 Dec; 662(2):220-5. PubMed ID: 7317438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucolipidosis I: studies of sialidase activity and a prenatal diagnosis.
    Mueller OT; Wenger DA
    Clin Chim Acta; 1981 Feb; 109(3):313-24. PubMed ID: 7226521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuraminidase activities in sialidosis and mucolipidosis.
    Kuriyama M; Miyatake T; Owada M; Kitagawa T
    J Neurol Sci; 1982 May; 54(2):181-7. PubMed ID: 7097297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cherry red spot in sialidosis (mucolipidosis type I).
    Heroman JW; Rychwalski P; Barr CC
    Arch Ophthalmol; 2008 Feb; 126(2):270-1. PubMed ID: 18268224
    [No Abstract]   [Full Text] [Related]  

  • 15. Deficiency of neuraminidase in the sialidoses and the mucolipidoses.
    Den Tandt WR; Leroy JG
    Hum Genet; 1980; 53(3):383-8. PubMed ID: 7372342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis.
    Bonten EJ; Arts WF; Beck M; Covanis A; Donati MA; Parini R; Zammarchi E; d'Azzo A
    Hum Mol Genet; 2000 Nov; 9(18):2715-25. PubMed ID: 11063730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical basis of six different types of sialidosis.
    Strecker G; Michalski JC
    FEBS Lett; 1978 Jan; 85(1):20-4. PubMed ID: 620790
    [No Abstract]   [Full Text] [Related]  

  • 18. Thymoquinone from nutraceutical black cumin oil activates Neu4 sialidase in live macrophage, dendritic, and normal and type I sialidosis human fibroblast cells via GPCR Galphai proteins and matrix metalloproteinase-9.
    Finlay TM; Jayanth P; Amith SR; Gilmour A; Guzzo C; Gee K; Beyaert R; Szewczuk MR
    Glycoconj J; 2010 Apr; 27(3):329-48. PubMed ID: 20213245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice.
    de Geest N; Bonten E; Mann L; de Sousa-Hitzler J; Hahn C; d'Azzo A
    Hum Mol Genet; 2002 Jun; 11(12):1455-64. PubMed ID: 12023988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialidosis and galactosialidosis: chromosomal assignment of two genes associated with neuraminidase-deficiency disorders.
    Mueller OT; Henry WM; Haley LL; Byers MG; Eddy RL; Shows TB
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1817-21. PubMed ID: 3081902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.